| PERIOD ENDING | 31-Dec-08 |
| Total Revenue | 2,525 |
| Cost of Revenue | 964 |
|
| Gross Profit | 1,561 |
|
| Operating Expenses |
| Research Development |
-
|
| Selling General and Administrative | 2,262 |
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | (701) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
| Earnings Before Interest And Taxes | (701) |
| Interest Expense | 7 |
| Income Before Tax | (708) |
| Income Tax Expense | (242) |
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | (466) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | (466) |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | ($466) |
0.11% Nasdaq 0.00%
Income Statement
